MarketInOut Stock Screener Log In | Sign Up

Panacea Biotec Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/28/2026 10:09
Panacea Biotec Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization19,030 mln
Float15.85 mln

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.13
Reliable

Relative Strength

34 / 100
Underperforming

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-2%
Barely loss-making

ROE

-0.86
Negative

Business Description

Panacea Biotec is an India-based biotechnology company founded in 1984 that develops, manufactures, and sells vaccines, medicines, health supplements, and children's nutrition products both domestically and in around 50 countries worldwide. Its medical portfolio spans a wide range of treatment areas, including cancer care, diabetes, and kidney disease, alongside vaccines for diseases such as dengue, typhoid, hepatitis A, and COVID-19. The company works with partners like the Russian Direct Investment Fund and the Indian Council of Medical Research to advance its vaccine programs, and also holds interests in real estate.

Key Fundamentals

EPS-1.16
ROE-0.86
RPS111
ROIC-2.66
ROA-0.55
Interest Cover-4.77
EBITDA, mln286
EV / EBITDA77.98
EV / EBIT-559
Revenue, mln6,726
EV / Revenue3.31

Quote Details

Last 322.90
Change 5.9 (1.86%)
Open 318.45
Volume 158
Turnover 51,018
Average Volume 3,435.33

Financial Ratios

Pre-Tax Profit Margin-2
Current Ratio1.47
Price / Book2.70
Price / Tangible Book2.88
Debt / Equity0.03
Price / Sales3.32

Financial Strength

Altman Z-Score4.4
Piotroski F-Score 6 / 9
Beneish M-Score-3.13
Shiller PE Ratio36.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.58% 26 / 100   
1 Month -13.69% 24 / 100   
2 Months -34.71% 5 / 100   
6 Months -12.58% 42 / 100   
1 Year -27.38% 35 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog